Drugs / GSK 138842A
last change Mar 2009 re-read 2 minutes ago

GSK 138842A

also known as 138842A
Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00693706 Jun 2008 → Mar 2009 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK 138842A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00693706
Known as 138842A “cell-culture based influenza vaccine 138842ANCT00693706